No Data
No Data
Tonghua Jinma (000766.SZ): Net profit of 9.1862 million yuan in the first quarter increased by 31.94% year-on-year
Gelonghui, April 22 | Tonghua Jinma (000766.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 296 million yuan, down 4.21% year on year; net profit attributable to shareholders of listed companies was 9.1862 million yuan, up 31.94% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 6.3369 million yuan, up 33.43% year on year; basic earnings per share were 0.0095 yuan.
Tonghua Jinma (000766.SZ) announced first-quarter results, net profit of 9.1863 million yuan, an increase of 31.94%
Tonghua Jinma (000766.SZ) released its report for the first quarter of 2024, achieving an operating income of 2.9 during the reporting period...
Express News | Tonghua Jinma: Net profit of 43.93 million yuan in 2023 increased by 45.71% year-on-year
Express News | Zhejiang Zhenyuan: The company and Tonghua Jinma Pharmaceutical Group are engaged in procurement business.
Tonghua Jinma (000766.SZ): The amber octahydroaminoacridine tablets developed by the company are mainly used to treat mild to moderate Alzheimer's disease
Gelonghui March 4 | Tonghua Jinma (000766.SZ) said on the investor interactive platform on March 4 that the amber octahydroaminoacridine tablets developed by our company are mainly used to treat mild to moderate Alzheimer's disease.
Tonghua Jinma (000766.SZ): The company adjusted the product structure of the compound Lactobacillus acidophilus tablets to ensure market supply of products with key specifications
Gelonghui, Feb. 29丨Tonghua Jinma (000766.SZ) said on the investor interactive platform that according to the national health insurance policy, the company has adjusted the product structure of compound Lactobacillus acidophilus tablets within the company to ensure market supply of products with key specifications.
No Data